Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xuqing Huang, Junqi Zhu, Yuyue Jiang, Changqing Xu, Qun Lv, Dongwei Yu, Kai Shi, Zhaoyang Ruan & Yan Wang. (2019) SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells. Drug Design, Development and Therapy 13, pages 1763-1772.
Read now
Read now
Articles from other publishers (35)
Shivang Dhoundiyal, Md Aftab Alam, Awaneet Kaur & Shaweta Sharma. (2024) Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases. Pharmaceutical Nanotechnology 12:1, pages 14-31.
Crossref
Crossref
Hamza Boucetta, Lei Zhang, Alejandro Sosnik & Wei He. (2024) Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies. Journal of Controlled Release 365, pages 236-258.
Crossref
Crossref
Zhaokui Jin, Qi Gao, Keke Wu, Jiang Ouyang, Weisheng Guo & Xing-Jie Liang. (2023) Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy. Advanced Drug Delivery Reviews 202, pages 115111.
Crossref
Crossref
Qinqin Fei, Ian Bentley, Samir N. Ghadiali & Joshua A. Englert. (2023) Pulmonary drug delivery for acute respiratory distress syndrome. Pulmonary Pharmacology & Therapeutics 79, pages 102196.
Crossref
Crossref
Sujata Maurya, Rashi Srivastava, Saniya Arfin, Susan Hawthorne, Niraj Kumar Jha, Kirti Agrawal, Sibi Raj, Brijesh Rathi, Arun Kumar, Riya Raj, Sharad Agrawal, Ana Cláudia Paiva-Santos, Asrar Ahmad Malik, Kamal Dua, Rakesh Rana, Shreesh Ojha, Saurabh Kumar Jha, Ankur Sharma, Dhruv Kumar, Sally A El-ZahabyAmka Nagar. (2022) Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases. Nanomedicine 17:30, pages 2245-2264.
Crossref
Crossref
Jiale Ju, Yinghua Wu, Wen He, Lin Zhan, Xuelian Yin, Junfeng Zhang, Yuxi Zhang, Li Qiu, Pir Muhammad, Rui L. Reis & Chenchen Li. (2022) Nanocarriers for Active Ingredients of Chinese Medicine (AIFCM) Used in Gastrointestinal Cancer Therapy. Journal of Biomedical Nanotechnology 18:10, pages 2279-2314.
Crossref
Crossref
Yi-Xuan Li, Hong-Bo Wang, Jing Li, Jian-Bo Jin, Jing-Bo Hu & Chun-Lin Yang. (2022) Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases. Frontiers in Pharmacology 13.
Crossref
Crossref
Juan A. De De Pablo-Moreno, Luis Javier Serrano, Luis Revuelta, María José Sánchez & Antonio Liras. (2022) The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V. International Journal of Molecular Sciences 23:15, pages 8283.
Crossref
Crossref
Rubiya Khursheed, Keshav R Paudel, Monica Gulati, Sukriti Vishwas, Niraj Kumar Jha, Philip M Hansbro, Brian G Oliver, Kamal Dua & Sachin Kumar Singh. (2022) Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks. Nanomedicine 17:12, pages 881-911.
Crossref
Crossref
Tomohiro Akiyama, Shinnosuke Hatakeyama, Kazuhisa Kawamoto, Hideko Nihei, Takamichi Hirata & Tomohiro Nomura. (2022) An Externally-Applied, Natural-Mineral-Based Novel Nanomaterial IFMC Improves Cardiopulmonary Function under Aerobic Exercise. Nanomaterials 12:6, pages 980.
Crossref
Crossref
Nura A. Mohamed, Isra Marei, Sergio Crovella & Haissam Abou-Saleh. (2022) Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases. International Journal of Molecular Sciences 23:3, pages 1404.
Crossref
Crossref
Jacob W. Myerson, Priyal N. Patel, Kathryn M. Rubey, Marco E. Zamora, Michael H. Zaleski, Nahal Habibi, Landis R. Walsh, Yi-Wei Lee, David C. Luther, Laura T. Ferguson, Oscar A. Marcos-Contreras, Patrick M. Glassman, Liudmila L. Mazaleuskaya, Ian Johnston, Elizabeth D. Hood, Tea Shuvaeva, Jichuan Wu, Hong-Ying Zhang, Jason V. Gregory, Raisa Y. Kiseleva, Jia Nong, Tilo Grosser, Colin F. Greineder, Samir Mitragotri, George S. Worthen, Vincent M. Rotello, Joerg Lahann, Vladimir R. Muzykantov & Jacob S. Brenner. (2021) Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation. Nature Nanotechnology 17:1, pages 86-97.
Crossref
Crossref
Ruonan Su, Yu Zhang, Jiabin Zhang, Haixia Wang, Yun Luo, Hon Fai Chan, Yu Tao, Zhuanggui Chen & Mingqiang Li. (2021) Nanomedicine to advance the treatment of bacteria-induced acute lung injury. Journal of Materials Chemistry B 9:44, pages 9100-9115.
Crossref
Crossref
Qi Qiao, Xiong Liu, Ting Yang, Kexin Cui, Li Kong, Conglian Yang & Zhiping Zhang. (2021) Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design. Acta Pharmaceutica Sinica B 11:10, pages 3060-3091.
Crossref
Crossref
Alba García-Fernández, Félix Sancenón & Ramón Martínez-Máñez. (2021) Mesoporous silica nanoparticles for pulmonary drug delivery. Advanced Drug Delivery Reviews 177, pages 113953.
Crossref
Crossref
Qingliang Yang, Harshani Wijerathne, Jordan C. Langston, Mohammad F. Kiani & Laurie E. Kilpatrick. (2021) Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. International Journal of Molecular Sciences 22:15, pages 7770.
Crossref
Crossref
Junchao Xu, Yinlong Zhang & Guangjun Nie. (2021) Intelligent antithrombotic nanomedicines: Progress, opportunities, and challenges. View 2:2, pages 20200145.
Crossref
Crossref
Zicheng Deng, Gregory T. Kalin, Donglu Shi & Vladimir V. Kalinichenko. (2021) Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases. American Journal of Respiratory Cell and Molecular Biology 64:3, pages 292-307.
Crossref
Crossref
Nura A. Mohamed, Haissam Abou-Saleh, Yu Kameno, Isra Marei, Gilberto de Nucci, Blerina Ahmetaj-Shala, Fisnik Shala, Nicholas S. Kirkby, Lewis Jennings, Dana E. Al-Ansari, Robert P. Davies, Paul D. Lickiss & Jane A. Mitchell. (2021) Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Scientific Reports 11:1.
Crossref
Crossref
Ruginn Catarata, Nilab Azim, Santanu Bhattacharya & Lei Zhai. (2020) Controlled drug release from polyelectrolyte–drug conjugate nanoparticles. Journal of Materials Chemistry B 8:14, pages 2887-2894.
Crossref
Crossref
Elizabeth D. Hood, Colin F. Greineder, Tea Shuvaeva, Landis Walsh, Carlos H. Villa & Vladimir R. Muzykantov. (2018) Vascular Targeting of Radiolabeled Liposomes with Bio-Orthogonally Conjugated Ligands: Single Chain Fragments Provide Higher Specificity than Antibodies. Bioconjugate Chemistry 29:11, pages 3626-3637.
Crossref
Crossref
Jacob S. Brenner, Daniel C. Pan, Jacob W. Myerson, Oscar A. Marcos-Contreras, Carlos H. Villa, Priyal Patel, Hugh Hekierski, Shampa Chatterjee, Jian-Qin Tao, Hamideh Parhiz, Kartik Bhamidipati, Thomas G. Uhler, Elizabeth D. Hood, Raisa Yu. Kiseleva, Vladimir S. Shuvaev, Tea Shuvaeva, Makan Khoshnejad, Ian Johnston, Jason V. Gregory, Joerg Lahann, Tao Wang, Edward Cantu, William M. Armstead, Samir Mitragotri & Vladimir Muzykantov. (2018) Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude. Nature Communications 9:1.
Crossref
Crossref
Colin F. Greineder, Carlos H. Villa, Landis R. Walsh, Raisa Y. Kiseleva, Elizabeth D. Hood, Makan Khoshnejad, Robert Warden-Rothman, Andrew Tsourkas & Vladimir R. Muzykantov. (2017) Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting. Bioconjugate Chemistry 29:1, pages 56-66.
Crossref
Crossref
Jacob S. Brenner, Raisa Yu. Kiseleva, Patrick M. Glassman, Hamideh Parhiz, Colin F. Greineder, Elizabeth D. Hood, Vladimir V. Shuvaev & Vladimir R. Muzykantov. (2018) The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series). Pulmonary Circulation 8:1, pages 1-18.
Crossref
Crossref
Nura A. Mohamed, Robert P. Davies, Paul D. Lickiss, Blerina Ahmetaj‐Shala, Daniel M. Reed, Hime H. Gashaw, Hira Saleem, Gemma R. Freeman, Peter M. George, Stephen J. Wort, Daniel Morales‐Cano, Bianca Barreira, Teresa D. Tetley, Adrian H. Chester, Magdi H. Yacoub, Nicholas S. Kirkby, Laura Moreno & Jane A. Mitchell. (2017) Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy. Pulmonary Circulation 7:3, pages 643-653.
Crossref
Crossref
Nuala J Meyer & Carolyn S Calfee. (2017) Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome. The Lancet Respiratory Medicine 5:6, pages 512-523.
Crossref
Crossref
Jacob S. Brenner, Kartik Bhamidipati, Patrick M. Glassman, N. Ramakrishnan, Depeng Jiang, Andrew J. Paris, Jacob W. Myerson, Daniel C. Pan, Vladimir V. Shuvaev, Carlos H. Villa, Elizabeth D. Hood, Raisa Kiseleva, Colin F. Greineder, Ravi Radhakrishnan & Vladimir R. Muzykantov. (2017) Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. Nanomedicine: Nanotechnology, Biology and Medicine 13:4, pages 1495-1506.
Crossref
Crossref
Jacob S. Brenner. (2017) Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome. The 2016 ATS Bear Cage Award–winning Proposal. Annals of the American Thoracic Society 14:4, pages 561-564.
Crossref
Crossref
Aaron C. Anselmo & Samir Mitragotri. (2017) Impact of particle elasticity on particle-based drug delivery systems. Advanced Drug Delivery Reviews 108, pages 51-67.
Crossref
Crossref
Katherine W. Pulsipher & Ivan J. Dmochowski. (2016) Ferritin: Versatile Host, Nanoreactor, and Delivery Agent. Israel Journal of Chemistry 56:9-10, pages 660-670.
Crossref
Crossref
Jacob W. Myerson, Aaron C. Anselmo, Yaling Liu, Samir Mitragotri, David M. Eckmann & Vladimir R. Muzykantov. (2016) Non-affinity factors modulating vascular targeting of nano- and microcarriers. Advanced Drug Delivery Reviews 99, pages 97-112.
Crossref
Crossref
Makan Khoshnejad, Vladimir V. Shuvaev, Katherine W. Pulsipher, Chuanyun Dai, Elizabeth D. Hood, Evguenia Arguiri, Melpo Christofidou-Solomidou, Ivan J. Dmochowski, Colin F. Greineder & Vladimir R. Muzykantov. (2016) Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles. Bioconjugate Chemistry 27:3, pages 628-637.
Crossref
Crossref
A.P. Ingle, S. Shende, R. Pandit, P. Paralikar, S. Tikar, K. Kon & M. Rai. 2016. The Microbiology of Respiratory System Infections. The Microbiology of Respiratory System Infections
223
235
.
Jacob W. Myerson, Jacob S. Brenner, Colin F. Greineder & Vladimir R. Muzykantov. (2015) Systems approaches to design of targeted therapeutic delivery. WIREs Systems Biology and Medicine 7:5, pages 253-265.
Crossref
Crossref
Daniel J Sobczynski, Margaret B Fish, Catherine A Fromen, Mariana Carasco-Teja, Rhima M Coleman & Omolola Eniola-Adefeso. (2015) Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems. Therapeutic Delivery 6:8, pages 915-934.
Crossref
Crossref